Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for Exercise-Induced PAH in Adult Congenital Heart Disease
NCT01827059Phase 2Unknown
- Sponsor
- University of Amsterdam
- Start
- Oct 2013
- Primary completion
- Feb 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by University of Amsterdam. Status: unknown.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01827059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01827059.